May 16, 2016
AbSci announced today the appointment of V. Bryan Lawlis, Ph.D. to AbSci’s Board of Directors. Dr. Lawlis has been the CEO and founder of numerous biotechnology companies and currently serves on the Board of Directors of BioMarin Pharmaceutical, Inc., Coherus...
May 16, 2016
AbSci, which manufactures soluble microbial proteins, said it secured $5.1 million in a round of Series A financing that it plans to use to speed up commercialization of its protein expression platform used in biopharmaceutical manufacturing. The fundraising was led...